ZOMIG

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, Singapore, South Africa, Spain, UK.

Active ingredients

The drug ZOMIG contains one active pharmaceutical ingredient (API):

1	Zolmitriptan UNII 2FS66TH3YW - ZOLMITRIPTAN
	Zolmitriptan has been demonstrated to be a selective agonist for the vascular human recombinant 5HT1B and 5HT1D receptor subtypes. Zolmitriptan is a high affinity 5HT1B/1D receptor agonist with modest affinity for 5HT1A receptors.
	Read more about Zolmitriptan

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZOMIG Film-coated tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
ZOMIG Nasal spray	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02CC03	Zolmitriptan	N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CC Selective serotonin (5HT1) agonists
Discover more medicines within N02CC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8266C
BR	Câmara de Regulação do Mercado de Medicamentos	542818090002117, 542818090002217
CA	Health Products and Food Branch	02238660, 02243045, 02248992, 02248993
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00784674, 02759982, 09279156
EE	Ravimiamet	1110722, 1110733, 1179716
ES	Centro de información online de medicamentos de la AEMPS	3110988, 34009, 61826, 62928, 65163, 65795
FI	Lääkealan turvallisuus- ja kehittämiskeskus	005303, 184432, 435594
FR	Base de données publique des médicaments	68232350, 68354386
GB	Medicines & Healthcare Products Regulatory Agency	139961, 139963, 147367, 21567, 36406, 373755, 373757, 48207, 81566
HK	Department of Health Drug Office	43324
HR	Agencija za lijekove i medicinske proizvode	HR-H-271461417, HR-H-878091382
IE	Health Products Regulatory Authority	57916, 57947, 57974, 58020, 58026
IL	מִשְׂרַד הַבְּרִיאוּת	3617
IT	Agenzia del Farmaco	033345012, 033345149
JP	医薬品医療機器総合機構	2160004F1027, 2160004F2023
LT	Valstybinė vaistų kontrolės tarnyba	1003212, 1086335, 1088487, 1093339
MT	Medicines Authority	AA227/00703, AA908/20401
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	356M2000, 612M97
NL	Z-Index G-Standaard, PRK	47651, 55727
SG	Health Sciences Authority	11816P
US	FDA, National Drug Code	64896-671, 64896-672, 64896-681, 64896-682, 64896-691, 64896-692
ZA	Health Products Regulatory Authority	32/7.3/0479, 34/7.3/0107, 36/7.3/0133